1. Home
  2. PGEN vs KIDS Comparison

PGEN vs KIDS Comparison

Compare PGEN & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • KIDS
  • Stock Information
  • Founded
  • PGEN 1998
  • KIDS 2007
  • Country
  • PGEN United States
  • KIDS United States
  • Employees
  • PGEN N/A
  • KIDS N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • KIDS Medical/Dental Instruments
  • Sector
  • PGEN Health Care
  • KIDS Health Care
  • Exchange
  • PGEN Nasdaq
  • KIDS Nasdaq
  • Market Cap
  • PGEN 493.0M
  • KIDS 524.3M
  • IPO Year
  • PGEN N/A
  • KIDS 2017
  • Fundamental
  • Price
  • PGEN $4.39
  • KIDS $17.10
  • Analyst Decision
  • PGEN Buy
  • KIDS Strong Buy
  • Analyst Count
  • PGEN 5
  • KIDS 7
  • Target Price
  • PGEN $7.50
  • KIDS $27.14
  • AVG Volume (30 Days)
  • PGEN 5.2M
  • KIDS 213.3K
  • Earning Date
  • PGEN 11-13-2025
  • KIDS 10-28-2025
  • Dividend Yield
  • PGEN N/A
  • KIDS N/A
  • EPS Growth
  • PGEN N/A
  • KIDS N/A
  • EPS
  • PGEN N/A
  • KIDS N/A
  • Revenue
  • PGEN $4,340,000.00
  • KIDS $220,733,000.00
  • Revenue This Year
  • PGEN $249.10
  • KIDS $17.32
  • Revenue Next Year
  • PGEN $710.03
  • KIDS $13.56
  • P/E Ratio
  • PGEN N/A
  • KIDS N/A
  • Revenue Growth
  • PGEN N/A
  • KIDS 26.08
  • 52 Week Low
  • PGEN $0.65
  • KIDS $15.28
  • 52 Week High
  • PGEN $5.23
  • KIDS $32.00
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 67.29
  • KIDS 41.22
  • Support Level
  • PGEN $3.85
  • KIDS $17.15
  • Resistance Level
  • PGEN $4.24
  • KIDS $18.15
  • Average True Range (ATR)
  • PGEN 0.29
  • KIDS 0.73
  • MACD
  • PGEN 0.10
  • KIDS 0.04
  • Stochastic Oscillator
  • PGEN 92.79
  • KIDS 58.56

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About KIDS OrthoPediatrics Corp.

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Share on Social Networks: